David M. Stack - Jan 25, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jan 25, 2022
Transactions value $
$147,773
Form type
4
Date filed
1/27/2022, 03:27 PM
Previous filing
Jan 13, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Options Exercise $148K +13.7K +12.5% $10.81 123K Jan 25, 2022 Direct
holding PCRX Common Stock 97.3K Jan 25, 2022 By Three Colleens Investment, LLC F1
holding PCRX Common Stock 18.6K Jan 25, 2022 By Stack Schroon Mohawk FLP F1
holding PCRX Common Stock 315 Jan 25, 2022 LCK Investment LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCRX Stock Option (Right to Buy) Options Exercise $0 -13.7K -23.3% $0.00 45K Jan 25, 2022 Common Stock 13.7K $10.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
F2 The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.